15859311000001100: Laropiprant (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with hormone receptor antagonist mechanism of action\Laropiprant

\Drug or medicament\Substance with hormone receptor antagonist mechanism of action\Laropiprant

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

55774901000001112 Laropiprant (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

55775001000001112 Laropiprant en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Laropiprant	Is a	Substance with hormone receptor antagonist mechanism of action	true	Inferred relationship	Existential restriction modifier
Laropiprant	Is a	Hormone, synthetic hormone substitute or hormone antagonist	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets	Has specific active ingredient	True	Laropiprant	Inferred relationship	Existential restriction modifier
Tredaptive 1000mg/20mg modified-release tablets (Organon Pharma (UK) Ltd)	Has specific active ingredient	True	Laropiprant	Inferred relationship	Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets 56 tablet	Has specific active ingredient	True	Laropiprant	Inferred relationship	Existential restriction modifier
Nicotinic acid 1g / Laropiprant 20mg modified-release tablets 28 tablet	Has specific active ingredient	True	Laropiprant	Inferred relationship	Existential restriction modifier
Tredaptive 1000mg/20mg modified-release tablets (Organon Pharma (UK) Ltd) 28 tablet 2 x 14 tablets	Has specific active ingredient	True	Laropiprant	Inferred relationship	Existential restriction modifier
Tredaptive 1000mg/20mg modified-release tablets (Organon Pharma (UK) Ltd) 56 tablet 4 x 14 tablets	Has specific active ingredient	True	Laropiprant	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets